Coherus Oncology, Inc. (CHRS)
Biological Products, (No Diagnostic Substances) · Healthcare · $4.4B
Intrinsic Value (Consensus)
$21.24
Current Price
$28.60
Margin of Safety
-25.7%
25.7% Above Intrinsic Value
Value: $21
Price: $29
Valuation Model Estimates
Current Price: $28.60
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$3.57
Earnings Power Value
$13.88
Relative Value (P/E)
$28.60
Dividend Discount Model
Not applicable
—
Consensus Value
$21.24
Model Assumptions
Discount Rate
10.3%
Growth Rate
20.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Key Financials
- EPS (TTM)
- $1.43
- EPS (Forward)
- $1.72
- Book Value
- $0.40
- P/E Ratio
- 20.0
- Forward P/E
- 16.7
- PEG Ratio
- —
- ROE
- 275.4%
- Debt/Equity
- 121%
- Revenue Growth
- 10.9%
- Earnings Growth
- 20.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Data last updated: 2026-06-12
Source: Yahoo Finance